Search Results - Amar Gajjar
- Showing 1 - 20 results of 182
- Go to Next Page
-
1
Atypical Teratoid Rhabdoid Tumor: Current Therapy and Future Directions by Kevin Ginn, Amar Gajjar
Published 2012Artigo -
2
Chemotherapy for Malignant Brain Tumors of Childhood by Nicholas G. Gottardo, Amar Gajjar
Published 2008Revisão -
3
Outcome and prognostic features in pediatric gliomas by Ibrahim Qaddoumi, Iyad Sultan, Amar Gajjar
Published 2009Artigo -
4
-
5
-
6
-
7
-
8
-
9
Challenging issues in pediatric oncology by Ching‐Hon Pui, Amar Gajjar, Javier R. Kane, Ibrahim Qaddoumi, Alberto S. Pappo
Published 2011Revisão -
10
-
11
-
12
Critical Combinations of Radiation Dose and Volume Predict Intelligence Quotient and Academic Achievement Scores After Craniospinal Irradiation in Children With Medulloblastoma by Thomas E. Merchant, Jane E. Schreiber, Shengjie Wu, Renin Lukose, Xiaoping Xiong, Amar Gajjar
Published 2014Artigo -
13
-
14
-
15
-
16
-
17
-
18
Cumulative cisplatin dose is not associated with event‐free or overall survival in children with newly diagnosed average‐risk medulloblastoma treated with cisplatin based adjuvant... by Amulya A. Nageswara Rao, Dana Wallace, Catherine A. Billups, James M. Boyett, Amar Gajjar, Roger J. Packer
Published 2013Artigo -
19
Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial by Adam Levy, Mark Krailo, Susan Chi, Doojduen Villaluna, Linda Springer, Chris Williams‐Hughes, Maryam Fouladi, Amar Gajjar
Published 2021Artigo -
20
Search Tools:
Related Subjects
Medicine
Internal medicine
Oncology
Pathology
Cancer research
Biology
Medulloblastoma
Chemotherapy
Genetics
Gene
Radiation therapy
Surgery
Glioma
Cancer
Pediatrics
Ependymoma
Psychiatry
Cognition
Radiology
Cohort
Physics
Bioinformatics
Brain tumor
Gastroenterology
Gene expression
Neurocognitive
Cisplatin
Neuroscience
Clinical trial
Regimen